Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 2, 2023
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Nicolas Garel, Kyle T Greenway, Lê-Anh L Dinh-Williams, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
March 5, 2026
A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients
Michka Nazon, Paola Lavin, C William Pike, et al.
Frontiers in Psychiatry
|
October 5, 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Scientific Reports
|
July 17, 2024
Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, et al.
BMJ Open
|
March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial
Christina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 18, 2025
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression
Kyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 30, 2025
Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matching
Kellie Elkrief, Paola Lavin, Kyle T Greenway, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 2, 2023
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
Nicolas Garel, Kyle T Greenway, Lê-Anh L Dinh-Williams, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|
March 5, 2026
A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients
Michka Nazon, Paola Lavin, C William Pike, et al.
Frontiers in Psychiatry
|
October 5, 2023
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression
Nicolas Garel, Jessica Drury, Julien Thibault Lévesque, et al.
Scientific Reports
|
July 17, 2024
Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, et al.
BMJ Open
|
March 20, 2026
The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial
Christina McAnulty, Philippe Lavoie, Samuel Cyr, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 18, 2025
The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression
Kyle T Greenway, Nicolas Garel, Lê-Anh L Dinh-Williams, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 30, 2025
Heart transplant outcomes in patients with substance use disorder history: a nationwide cohort study using high-dimensional propensity score matching
Kellie Elkrief, Paola Lavin, Kyle T Greenway, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Page
of 4